on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. has released its Form 8.3 in compliance with Rule 8.3 of the Irish Takeover Panel Act, revealing its current position in Mural Oncology plc. The disclosure, dated October 24, 2025, pertains to securities within the company.
Vanguard controls 288,859 ordinary shares, representing a 1.67% stake. This filing does not indicate involvement with other parties to the offer. The transaction included a recent purchase of $0.01 ordinary shares at a price of $2.09 USD per unit.
No cash-settled or stock-settled positions are reported, nor are there any options or agreements related to new securities. There are no disclosed indemnity or other agreement arrangements, nor any attachments offered with this form.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news